Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-10-30
2007-10-30
Romeo, David S (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S093210
Reexamination Certificate
active
11179271
ABSTRACT:
Stem cells are mobilized into the peripheral blood by a method comprising the steps of: (i) administering to an individual at least one of the following: FGF1 and FGF2, and also at least one of the following: VEGF, VEGFA, VEGFB, PLGF, VEGF121, VEGF145, VEGF165, VEGF189, and VEGF206; (ii) isolating the peripheral blood stem cells (PBSC) by apheresis; and (iii) treating a patient suffering from organ disease with PBSC. Alternatively, gene therapy is used for the induction of the stem cells into the peripheral blood, wherein the gene therapy formulation comprises AD5FGF-4 or VEGF165 plasmid DNA. Additionally, the progress of the treatment of the organ disease is monitored by using an ultrasound unit.
REFERENCES:
patent: 5932540 (1999-08-01), Hu et al.
patent: 6352971 (2002-03-01), Deischer et al.
patent: 6482406 (2002-11-01), Stewart
patent: 6608182 (2003-08-01), Rosen et al.
patent: 6673604 (2004-01-01), Edge
patent: 6716626 (2004-04-01), Itoh et al.
patent: 6734285 (2004-05-01), Hu et al.
patent: 6775574 (2004-08-01), Soykan et al.
patent: 6852533 (2005-02-01), Rafii et al.
patent: 2002/0090722 (2002-07-01), Dominko et al.
patent: 2002/0142457 (2002-10-01), Umezawa
patent: 2002/0172663 (2002-11-01), Palasis
patent: 2003/0022367 (2003-01-01), Xu
patent: 2003/0023995 (2003-01-01), Benezra
patent: 2003/0082148 (2003-05-01), Ludwig et al.
patent: 2003/0103951 (2003-06-01), Pittenger et al.
patent: 2003/0199464 (2003-10-01), Itescu
patent: 2003/0211994 (2003-11-01), Li et al.
patent: 2003/0219898 (2003-11-01), Sugaya et al.
patent: 2004/0018174 (2004-01-01), Palasis
patent: 2004/0028658 (2004-02-01), Faustman
patent: 2004/0033214 (2004-02-01), Young et al.
patent: 2004/0048375 (2004-03-01), Alt
patent: 2004/0071665 (2004-04-01), Xiao et al.
patent: 2004/0071687 (2004-04-01), Rafii et al.
patent: 2005/0026220 (2005-02-01), Rafii et al.
patent: 2005/0069527 (2005-03-01), Laughlin et al.
Cai et al., NeuroMolecular Medicine, 2002, vol. 2, p. 223-249.
“Stem Cells And Repair Of The Heart”,LancetJul. 10, 2004;364 (9429): 183-192.
“Stem Cells: biology and possible application to myocardial infarct”,Ned Tijdschr. GeneeskdJun. 12, 2004: 148 (24): 1186-91.
“Use Of Stem Cells For Myocardial Regeneration”,Cas Lek Cesk.2004; 143 (2): 71-4.
“Transcriptional Regulation of Cardian Progenitor Cell Populations”,Circulation Research95: 389-397.
“Gene and Cell-Based Therapies For Heart Disease”,FASEB J.Apr. 2004; 18 (6) 648-63.
“Transcriptional Regulation of Cardian Progenitor Cell Populations”,Circulation Research95: 389-397, 2004.
Buff Ernest D.
Ernest D. Buff & Associates LLC
Gamett Daniel C
Pierson Theodore J.
Romeo David S
LandOfFree
Growth factor therapy mobilization of stem cells into the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Growth factor therapy mobilization of stem cells into the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Growth factor therapy mobilization of stem cells into the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3886701